Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice

[1]  K. Gilchrist,et al.  Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. , 2002, The American journal of pathology.

[2]  S. Korsmeyer,et al.  c-Myc Functionally Cooperates with Bax To Induce Apoptosis , 2002, Molecular and Cellular Biology.

[3]  S. Korsmeyer,et al.  Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice. , 2002, Cancer research.

[4]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[5]  S. Markowitz,et al.  MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice , 2001, Oncogene.

[6]  M. Roussel,et al.  Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis , 2001, Molecular and Cellular Biology.

[7]  D. Andrews,et al.  Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria , 2001, Molecular and Cellular Biology.

[8]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[9]  R. Cardiff,et al.  c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations , 2001, Nature Medicine.

[10]  B. Trock,et al.  C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance , 2000, British Journal of Cancer.

[11]  John Calvin Reed,et al.  Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.

[12]  K. Hunter,et al.  An epistatic interaction controls the latency of a transgene-induced mammary tumor , 2000, Mammalian Genome.

[13]  V. Steele,et al.  Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  John Calvin Reed,et al.  The Putative Pore-Forming Domain of Bax Regulates Mitochondrial Localization and Interaction with Bcl-XL , 2000, Molecular and Cellular Biology.

[15]  R. Dickson,et al.  Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models , 2000, Oncogene.

[16]  R. Cardiff,et al.  The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.

[17]  J. Martinou,et al.  Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. , 2000, The Biochemical journal.

[18]  K. Murphy,et al.  Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2 , 1999, Oncogene.

[19]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[20]  E. Schröck,et al.  A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV‐cmyc transgenic mice , 1999, Genes, chromosomes & cancer.

[21]  S. Korsmeyer,et al.  Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. , 1999, Cancer research.

[22]  G. Evan,et al.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.

[23]  S. Korsmeyer,et al.  Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40‐TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage , 1999, The EMBO journal.

[24]  G. Prendergast,et al.  Mechanisms of apoptosis by c-Myc , 1999, Oncogene.

[25]  J. Reed,et al.  Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer , 1999, Journal of Mammary Gland Biology and Neoplasia.

[26]  D. Felsher,et al.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Jean-Claude Martinou,et al.  Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis , 1999, The Journal of cell biology.

[28]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[29]  N. Drinkwater,et al.  Multiple genetic loci modify risk for retinoblastoma in transgenic mice. , 1998, Investigative ophthalmology & visual science.

[30]  K. Franssila,et al.  A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer. , 1998, British Journal of Cancer.

[31]  K. Buetow,et al.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression , 1998, International journal of cancer.

[32]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[33]  S. Ritland,et al.  Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. , 1998, Cancer research.

[34]  T. Ried,et al.  Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability , 1998, Oncogene.

[35]  J C Reed,et al.  Bax directly induces release of cytochrome c from isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Jäger,et al.  Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice , 1997, Oncogene.

[37]  F Gambale,et al.  Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[38]  E. Kouri,et al.  Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. , 1997, Anticancer research.

[39]  S. Nass,et al.  Defining a role for c-Myc in breast tumorigenesis , 1997, Breast Cancer Research and Treatment.

[40]  G. Brem,et al.  Epigenetic modification of transgenes under the control of the mouse mammary tumor virus LTR: tissue-dependent influence on transcription of the transgenes. , 1996, Biological chemistry.

[41]  L. Amundadottir,et al.  Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. , 1996, Oncogene.

[42]  T Takahashi,et al.  Overexpression of bax sensitizes human breast cancer MCF‐7 cells to radiation‐induced apoptosis , 1996, International journal of cancer.

[43]  B. Dörken,et al.  Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. , 1996, The Journal of clinical investigation.

[44]  S. Korsmeyer,et al.  Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.

[45]  A. Pellicer,et al.  Promoter demethylation in MMTV/N‐rasN transgenic mice required for transgene expression and tumorigenesis , 1995, Molecular carcinogenesis.

[46]  K. Franssila,et al.  Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. , 1995, Cancer research.

[47]  R. Palmiter,et al.  Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. , 1995, Cancer research.

[48]  J. Cleveland,et al.  c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.

[49]  L. Donehower,et al.  The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. , 1995, Oncogene.

[50]  L. Amundadottir,et al.  Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[51]  B. Dörken,et al.  Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis , 1995, International journal of cancer.

[52]  John Calvin Reed,et al.  Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. , 1994, The American journal of pathology.

[53]  G. Evan,et al.  c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.

[54]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[55]  G. Evan,et al.  The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.

[56]  R. Strange,et al.  Apoptotic cell death and tissue remodelling during mouse mammary gland involution. , 1992, Development.

[57]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[58]  G. Merlo,et al.  Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T , 1990, Journal of cellular physiology.

[59]  M. Osborne,et al.  Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. , 1990, Cell regulation.

[60]  R. Palmiter,et al.  Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.

[61]  G. Merlino,et al.  TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.

[62]  B. Hogan,et al.  Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice , 1990, Cell.

[63]  P. Leder,et al.  Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development , 1986, Cell.

[64]  P. Leder,et al.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.

[65]  B. Vennstrom,et al.  Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 , 1982, Journal of virology.

[66]  R. Brown,et al.  BCL-2 Family Proteins , 2019, Methods in Molecular Biology.

[67]  S. Thorgeirsson,et al.  Disruption of the pRb / E 2 F Pathway and Inhibition of Apoptosis Are Major Oncogemc Events in Liver Constitutively Expressing c-myc and Transforming Growth Factor a , 2006 .

[68]  T. Dimpfl,et al.  Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium , 1999, Cell and Tissue Research.

[69]  N. J. McNally,et al.  United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.

[70]  S. Thorgeirsson,et al.  Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. , 1998, Cancer research.

[71]  D. Brewster,et al.  Trends in cancer incidence and mortality in Scotland: description and possible explanations. , 1998, British Journal of Cancer.

[72]  L. Hennighausen,et al.  Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[73]  John Calvin Reed,et al.  Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma. , 1996, Cancer treatment and research.

[74]  S. Snedeker,et al.  Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[75]  B. Hogan,et al.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. , 1990, Cell.

[76]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.

[77]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.